AtaiBeckley cleared for Phase 3 trials of nasal spray depression treatment after FDA backing

The FDA has supported the Phase 3 design for BPL-003, an intranasal psychedelic-derived therapy for treatment-resistant ...

AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression

Aligned with FDA on dual-trial design Phase 3 program that aims to demonstrate robust efficacy and long-term safety and that allows for flexible dosingPhase 3 program initiation remains on track for ...

Scientel achieves 6 Trillion Parameter LLM run on Ohio State OSC Supercomputer

Trillion Parameter run achieved with DeepSeek R1 671B model on 36 Nvidia H100 GPUs We are pleased to offer a Trillion ...

LaFleur Minerals Announces Positive PEA Results for the Swanson Gold Deposit Highlighting Low CAPEX, Robust Economics, and Development Pathway to Gold Production at Its Beacon ...

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) ("LaFleur Minerals" or the "Company") is pleased to announce the results of its Preliminary Economic Assessment ("PEA") for the proposed ...
BMJ Open

Understanding integrated mental healthcare for people experiencing forced migration: a realist review protocol

Introduction Forced migrants (i.e., asylum seekers and refugees) experience greater mental health disparities and inequities in care. Mental health services and systems lack clear policy on integrated ...